Buch SC - Search Results

1

Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis.

Tawbi HA, Beumer JH, Tarhini AA, Moschos S, Buch SC, Egorin MJ, Lin Y, Christner S, Kirkwood JM. Tawbi HA, et al. Among authors: buch sc. Ann Oncol. 2013 Apr;24(4):1112-9. doi: 10.1093/annonc/mds591. Epub 2012 Nov 21. Ann Oncol. 2013. PMID: 23172636 Free PMC article. Clinical Trial.

2

Chemotherapy resistance abrogation in metastatic melanoma.

Tawbi HA, Buch SC. Tawbi HA, et al. Among authors: buch sc. Clin Adv Hematol Oncol. 2010 Apr;8(4):259-66. Clin Adv Hematol Oncol. 2010. PMID: 20505649 Review.

3

PARP1 rs1805407 Increases Sensitivity to PARP1 Inhibitors in Cancer Cells Suggesting an Improved Therapeutic Strategy.

Abecassis I, Sedgewick AJ, Romkes M, Buch S, Nukui T, Kapetanaki MG, Vogt A, Kirkwood JM, Benos PV, Tawbi H. Abecassis I, et al. Sci Rep. 2019 Mar 1;9(1):3309. doi: 10.1038/s41598-019-39542-2. Sci Rep. 2019. PMID: 30824778 Free PMC article.

4

MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603.

Villaruz LC, Huang G, Romkes M, Kirkwood JM, Buch SC, Nukui T, Flaherty KT, Lee SJ, Wilson MA, Nathanson KL, Benos PV, Tawbi HA. Villaruz LC, et al. Among authors: buch sc. Clin Epigenetics. 2015 Jun 4;7(1):58. doi: 10.1186/s13148-015-0092-2. eCollection 2015. Clin Epigenetics. 2015. PMID: 26052356 Free PMC article.

5

CYP24 inhibition preserves 1α,25-dihydroxyvitamin D(3) anti-proliferative signaling in lung cancer cells.

Zhang Q, Kanterewicz B, Buch S, Petkovich M, Parise R, Beumer J, Lin Y, Diergaarde B, Hershberger PA. Zhang Q, et al. Mol Cell Endocrinol. 2012 May 15;355(1):153-61. doi: 10.1016/j.mce.2012.02.006. Epub 2012 Feb 22. Mol Cell Endocrinol. 2012. PMID: 22386975 Free PMC article.

6

Inherited variation in the ATP-binding cassette transporter ABCB1 and survival after chemotherapy for stage III-IV lung cancer.

Weissfeld JL, Diergaarde B, Nukui T, Buch S, Pennathur A, Socinski MA, Siegfried JM, Romkes M. Weissfeld JL, et al. J Thorac Oncol. 2014 Sep;9(9):1264-71. doi: 10.1097/JTO.0000000000000262. J Thorac Oncol. 2014. PMID: 25122423 Free PMC article.

7

XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck.

Vaezi A, Wang X, Buch S, Gooding W, Wang L, Seethala RR, Weaver DT, D'Andrea AD, Argiris A, Romkes M, Niedernhofer LJ, Grandis JR. Vaezi A, et al. Clin Cancer Res. 2011 Aug 15;17(16):5513-22. doi: 10.1158/1078-0432.CCR-11-0086. Epub 2011 Jul 7. Clin Cancer Res. 2011. PMID: 21737503 Free PMC article.

8

Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent.

Zhong S, Nukui T, Buch S, Diergaarde B, Weissfeld LA, Grandis J, Romkes M, Weissfeld JL. Zhong S, et al. Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2429-37. doi: 10.1158/1055-9965.EPI-11-0520. Epub 2011 Sep 2. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21890746 Free PMC article.

9

Genotyping technologies: application to biotransformation enzyme genetic polymorphism screening.

Romkes M, Buch SC. Romkes M, et al. Among authors: buch sc. Methods Mol Biol. 2005;291:399-414. doi: 10.1385/1-59259-840-4:399. Methods Mol Biol. 2005. PMID: 15502238 Review.

10

Genotyping technologies: application to biotransformation enzyme genetic polymorphism screening.

Romkes M, Buch SC. Romkes M, et al. Among authors: buch sc. Methods Mol Biol. 2014;1105:99-115. doi: 10.1007/978-1-62703-739-6_8. Methods Mol Biol. 2014. PMID: 24623222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters